title: Depletion of alphaV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis.
abstract: Integrin heterodimers sharing the common alphaV subunit are receptors for adhesion glycoproteins such as vitronectin and fibronectin. They are suggested to play an essential role in cell anchoring, differentiation, and survival. Here, we describe the construction of an expression plasmid coding for an intracellular single-chain antibody against alphaV integrin subunit. Saos-2 osteosarcoma cells transfected with this DNA construct showed an approximately 70-100% decrease in the cell surface expression of alphaVbeta3 and alphaVbeta5 integrins as shown by flow cytometry. Intracellular antibody expression had no effect on the mRNA levels of alphaV integrin. Pulse chase experiments of metabolically labeled integrins showed that the translation of precursor alphaV integrin subunit was not affected. However, the maturation of alphaV integrins as glycoproteins was slow suggesting that the transport from endoplasmic reticulum to Golgi complex was partially prevented. Depletion of alphaV integrins from Saos-2 cells led to a decreased ability to spread on fibronectin and vitronectin. Furthermore, the expression of osteoblast differentiation marker genes, alkaline phosphatase and osteopontin, was induced and concomitantly the expression of matrix metalloproteinase-2 decreased. Thus, alphaV integrins seem to be important regulators of osteosarcoma cell phenotypes. Our data also indicate that the expression of intracellular antibodies is an effective strategy to study the significance of specific integrins for cell phenotype and differentiation.
authors.affiliation: MediCity Research Laboratory, University of Turku, Finland.
authors.forename: P
authors.initials: P
authors.lastname: Koistinen
authors.forename: T
authors.initials: T
authors.lastname: Pulli
authors.forename: V J
authors.initials: VJ
authors.lastname: Uitto
authors.forename: L
authors.initials: L
authors.lastname: Nissinen
authors.forename: T
authors.initials: T
authors.lastname: Hyypiä
authors.forename: J
authors.initials: J
authors.lastname: Heino
mesh_terms: D000469:Alkaline Phosphatase / Q000096:biosynthesis; D015703:Antigens, CD / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D015415:Biomarkers; D001842:Bone and Bones / Q000166:cytology* / Q000378:metabolism; D002448:Cell Adhesion; D002454:Cell Differentiation / Q000235:genetics; D004790:Enzyme Induction; D005353:Fibronectins / Q000378:metabolism; D006023:Glycoproteins / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D007128:Immunoglobulin Fragments / Q000235:genetics / Q000276:immunology; D039564:Integrin alphaV; D007424:Intracellular Fluid; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis* / Q000235:genetics; D053495:Osteopontin; D012516:Osteosarcoma; D012795:Sialoglycoproteins / Q000096:biosynthesis; D014407:Tumor Cells, Cultured; D019096:Vitronectin / Q000378:metabolism
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D005353:Fibronectins; D006023:Glycoproteins; D007128:Immunoglobulin Fragments; D039564:Integrin alphaV; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D019096:Vitronectin; D053495:Osteopontin; D000469:Alkaline Phosphatase; D020778:Matrix Metalloproteinase 2